Medidata Solutions Stock Company Profile

Description

Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. The company offers applications and data analytics for clinical development. It offers Medidata Clinical Cloud that provides a software-as-a-service platform of technology and data analytics solutions to optimize activities across clinical development. The company’s platform includes Planning Cloud that provides capabilities for study design and planning; and Medidata Rave, an electronic data capture and management system solution. Its platform solutions also include Patient Cloud for direct capture of the voice of the patient in clinical trials; Medidata's mobile health that offer various ways for customers to utilize the measurements in the scientific, regulatory, and technology environment of clinical trials; Medidata Patient Cloud ePRO, an application for use on various app-ready iOS or Android device; and Study Management Cloud that enable clinical teams to manage, monitor, control, integrate, and report operational and clinical data from patients and sites. Further, the company’s platform solutions include a set of risk-based monitoring tools and services that enable customers to assess data quality with risk-based strategies; Payments Cloud solution that automates the task of tracking and calculating payments to individual sites across clinical trials; and Data and Analytics Cloud to surface a range of embedded operational data across the clinical process. Additionally, it offers professional services. The company markets and sells its cloud-based solutions through a direct sales force, as well as through relationships with contract research organizations (CROs) and other strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and academic institutions, CROs, and other entities engaged in clinical trials. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York.